Thursday, 21 September 2023
World Forum, The Hague, The Netherlands
This is a promotional symposium for healthcare professionals only and includes promotional content on IMCIVREE®.
In this session, Professor Erica van den Akker (Erasmus University, Rotterdam), Professor Mieke van Haelst (Amsterdam UMC, Amsterdam), Dr Elizabeth Forsythe (Great Ormond Street and St Thomas’ Hospitals, London) and Dr Corjan de Groot (Erasmus University, Rotterdam) discuss hyperphagia, early-onset, severe obesity, and the role of precision medicine in the treatment of leptin melanocortin-4 receptor (MC4R) pathway diseases.
Professor Erica van den Akker
Rhythm Pharmaceuticals is leveraging a IQVIA's Healthcare Professional Authentication solution to identify your eligibility to access this video content. If you already have an IQVIA account using it with other healthcare providers, please click 'Login' otherwise click 'Signup'.
Professor Mieke van Haelst
Rhythm Pharmaceuticals is leveraging a IQVIA's Healthcare Professional Authentication solution to identify your eligibility to access this video content. If you already have an IQVIA account using it with other healthcare providers, please click 'Login' otherwise click 'Signup'.
Dr Elizabeth Forsythe
Rhythm Pharmaceuticals is leveraging a IQVIA's Healthcare Professional Authentication solution to identify your eligibility to access this video content. If you already have an IQVIA account using it with other healthcare providers, please click 'Login' otherwise click 'Signup'.
Dr Corjan de Groot
Rhythm Pharmaceuticals is leveraging a IQVIA's Healthcare Professional Authentication solution to identify your eligibility to access this video content. If you already have an IQVIA account using it with other healthcare providers, please click 'Login' otherwise click 'Signup'.
Prof Erica van den Akker
(The Netherlands)
Prof Mieke van Haelst
(The Netherlands)
Dr Elizabeth Forsythe
(UK)
Dr Corjan de Groot
(The Netherlands)
This meeting was organised and funded by Rhythm Pharmaceuticals and is intended for healthcare professionals only.